First-Line Mammalian Target of Rapamycin Inhibition in Metastatic Renal Cell Carcinoma: An Analysis of Practice Patterns From the International Metastatic Renal Cell Carcinoma Database Consortium

Using an established international renal cell carcinoma (RCC) database, we retrospectively characterized the use and efficacy of mammalian target of rapamycin (mTOR) inhibitors in treatment-naive metastatic RCC (mRCC) patients. Front-line mTOR inhibitors are used in clinical practice mostly in selec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Harshman, Lauren C., Kroeger, Nils, Rha, Sun Young, Donskov, Frede, Wood, Lori, Tantravahi, Srinivas K., Vaishampayan, Ulka, Rini, Brian I., Knox, Jennifer, North, Scott, Ernst, Scott, Yuasa, Takeshi, Srinivas, Sandy, Pal, Sumanta, Heng, Daniel Y., Choueiri, Toni K.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4164603/
https://ncbi.nlm.nih.gov/pubmed/24787966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2014.03.003
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge